Clinical Trial Update: Doxycycline to Protect Heart Muscle After Heart Attacks [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of doxycycline to protect heart muscle after ST-elevation myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• St-elevation Myocardial Infarction

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: University of Alberta | Conditions: ST Segment Elevation Myocardial Infarction, Heart Failure | Phase 2 | Status: COMPLETED